Back to results
US 2023/0053338 A1Published application
Pro-inflammatory and anti-cancer functions of toll-like receptor 4 antagonists
AssigneeChildren’s Medical Center Corporation
InventorJonathan C. Kagan
Life of this patent
Estimating the term…
Abstract
The present invention provides methods and compositions for specific activation of inflammatory responses in dendritic cells (DCs). 1-palmitoyl-2-arachidonyl-sn-glycero phosphorylcholine (PAPC) and its oxidized variant (oxPAPC) were identified to promote DC-mediated immunity, and are provided as adjuvants in immunostimulatory compositions, including vaccines.
Claims15
-25. (canceled)
A pharmaceutical composition comprising:
- (i) a TLR4 agonist, a TLR2 agonist, and/or a TLR9 agonist;
- (ii) an oxidated 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (oxPAPC) species;
- and (iii) a cancer immunogen.
Dependencies are inferred from the claim text.